KC
Insider buying
Kyle Carver bought $13K of EVMN stock
Kyle Carver, Chief Financial Officer of Evommune, Inc. (EVMN), bought 1,000 shares of EVMN stock worth $13K, per an SEC Form 4 filed Jul 10, 2026.
It was an open-market purchase.
The trade happened on Jul 8, 2026, 2 days before it was made public.
EVMN has moved -59.4% since the trade date, from $13.25 to $5.38 (Oct 20, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 2 days
- Price since
- -59.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More EVMN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.